Valuation of DENTSPLY SIRONA Inc. (XRAY): P/B 1.48, EV/EBITDA 16.8, dividend yield 1.59%. The price range it would trade at on its usual multiples and on its sector's, with its peers' multiples and a comparison against other Healthcare companies.
DENTSPLY SIRONA Inc. develops, manufactures, and markets dental equipment supported by cloud-enabled solutions, dental products, and healthcare consumable products in urology and enterology worldwide. It operates through four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare.
Analysis Summary
DENTSPLY SIRONA Inc. reported revenue of $3.68B in the most recent fiscal year, growing at a 5-year CAGR of 2.0%.
Trailing-twelve-month margins: gross margin 50.5%, operating margin 11.7%, net margin -3.4%.
At $10.09 (closing price, November 5, 2026), XRAY has negative trailing earnings (P/E not meaningful) and an ROE of -9.03%. Market capitalisation stands at $2.0B.
Balance sheet quality for XRAY: debt-to-equity ratio of 1.69, current ratio of 1.63 over the last 12 months. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| Price / Book | 1.48 |
| EV / EBITDA | 16.8 |
| Dividend Yield | 1.59% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| XRAY | DENTSPLY SIRONA Inc. | $2.0B | 1.48 | -9.0% | |
| ALGN | Align Technology, Inc. | $11.3B | 23.16 | 2.63 | 11.8% |
| HSIC | Henry Schein, Inc. | $9.5B | 23.37 | 3.00 | 13.1% |
| NVST | Envista Holdings Corp | $4.0B | 6.45 | 1.30 | 20.5% |
| ISRG | Intuitive Surgical, Inc. | $165.5B | 56.24 | 9.35 | 17.0% |
| 0R29.L | Intuitive Surgical, Inc. | $150.3B | 54.04 | 9.87 | 17.0% |
| BDX | Becton, Dickinson and Company | $58.2B | 51.58 | 1.15 | 3.7% |
| 0R19.L | Becton, Dickinson and Company | $54.2B | 59.91 | 2.24 | 3.8% |
Price
| Price | $10.09 (closing price, November 5, 2026) |
| Market Cap | $2.0B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | -9.03% |
| Return on Invested Capital | 9.96% |
| Return on Assets | -2.33% |
| Gross Margin | 50.52% |
| Operating Margin | 11.66% |
| Net Margin | -3.38% |
Related companies: ALGN · HSIC · NVST · ISRG · 0R29.L · BDX · 0R19.L · 0KW4.L
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of XRAY: Overview · Financials · Estimates · Technical · Ownership
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks